Beta cell extracellular vesicle PD-L1 as a novel regulator of CD8+ T cell activity and biomarker during the evolution of type 1 diabetes

Chaitra Rao,Daniel T. Cater,Saptarshi Roy,Jerry Xu,Andre G. De Oliveira,Carmella Evans-Molina,Jon D. Piganelli,Decio L. Eizirik,Raghavendra G. Mirmira,Emily K. Sims
DOI: https://doi.org/10.1007/s00125-024-06313-2
IF: 8.2
2024-11-09
Diabetologia
Abstract:Surviving beta cells in type 1 diabetes respond to inflammation by upregulating programmed death-ligand 1 (PD-L1) to engage immune cell programmed death protein 1 (PD-1) and limit destruction by self-reactive immune cells. Extracellular vesicles (EVs) and their cargo can serve as biomarkers of beta cell health and contribute to islet intercellular communication. We hypothesised that the inflammatory milieu of type 1 diabetes increases PD-L1 in beta cell EV cargo and that EV PD-L1 may protect beta cells against immune-mediated cell death.
endocrinology & metabolism
What problem does this paper attempt to address?